Related Experiment Video

Updated: Jun 27, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

NM23H2 inhibits EGF- and Ras-induced proliferation of NIH3T3 cells by blocking the ERK pathway

Mi-Young Lee1, Woo-Jeong Jeong, Jong-Won Oh

  • 1Department of Biotechnology, Protein Network Research Center, Yonsei University, 134 Shinchon-Dong, Seodemun-Gu, Seoul, Republic of Korea.

Cancer Letters
|November 22, 2008
PubMed

Insights

NM23H2 negatively regulates cellular proliferation. This NM23 family protein inhibits the extracellular signal-regulated kinase (ERK) pathway, impacting growth stimulated by epidermal growth factor (EGF) and Ras.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • NM23 family proteins are implicated in tumor metastasis, development, and differentiation.
  • The precise role of NM23 family members, particularly NM23H2, in regulating cellular proliferation remains unclear.
  • Understanding NM23H2's function is crucial for deciphering cancer progression mechanisms.

Purpose of the Study:

  • To investigate the role of NM23H2 in regulating cellular proliferation.
  • To determine NM23H2's involvement in the extracellular signal-regulated kinase (ERK) signaling pathway.
  • To elucidate how NM23H2 affects proliferation stimulated by epidermal growth factor (EGF) and oncogenic Ras.

Main Methods:

  • Utilized knockdown and overexpression techniques for NM23H2 in NIH3T3 and HEK293 cells.
  • Assessed ERK pathway activity through biochemical assays.
  • Investigated the impact of NM23H2 on EGF- and Ras(G12R)-induced cellular proliferation.

Main Results:

  • Knockdown of NM23H2 enhanced ERK activity, while overexpression inhibited it.
  • NM23H2 overexpression reduced EGF- and Ras(G12R)-induced proliferation in both cell lines.
  • NM23H2 inhibited the activation of Raf-1, MEK, and ERK kinases downstream of EGF and Ras signaling.

Conclusions:

  • NM23H2 functions as a negative regulator of cellular proliferation.
  • NM23H2 specifically inhibits proliferation driven by the EGF- and Ras-mediated activation of the ERK pathway.
  • These findings provide novel insights into the molecular mechanisms controlling cell growth and cancer metastasis.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...